Royalty Pharma plc - Class A — Quarterly Financial Statistics (NASDAQ:RPRX) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 703.61 M742.52 M596.08 M363.98 M702.62 M827.15 M 2.49 B Cash from investing activities 1.19 B505.59 M503.92 M-311.98 M574.44 M847.8 M 1.61 B Cash from financing activities -325.5 M-257.96 M941.3 M507.81 M-562.74 M299.6 M 1.19 B Free cash flow 703.61 M742.52 M596.08 M363.98 M702.62 M827.15 M 2.49 B

Nachrichten

Royalty Pharma: TD Cowen hebt Kursziel wegen Wachstumsaussichten auf 50 $ an/n

TD Cowen raises Royalty Pharma stock price target to $50 on growth

Royalty Pharma auf Rekordkurs: Aktie markiert neues 52-Wochen-Hoch

Royalty Pharma stock hits 52-week high at 46.14 USD

Royalty Pharma Stock: 2025 Financial Performance And Strategic Outlook (NASDAQ:RPRX)

The Week That Was, The Week Ahead: Macro and Markets, Feb. 15 - TipRanks.com

Dividend Champion, Contender, And Challenger Highlights: Week Of February 15

Royalty Pharma plc (RPRX) Q4 2025 Earnings Call Transcript

Royalty Pharma-Aktie markiert neues 52-Wochen-Hoch bei 44,94 USD

Royalty Pharma stock hits 52-week high at 44.94 USD

Royalty Pharma Q4 2025 slides: double-digit growth amid synthetic royalty expansion

Here's What Key Metrics Tell Us About Royalty Pharma (RPRX) Q4 Earnings